The George Washington University (GW) School of Medicine and Health Sciences Department of Dermatology will have a strong presence at the upcoming American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) reporting on both innovative bench and clinical research ongoing in the department. The meeting will be held virtually due to COVID-19 restrictions, April 23-25.
AAD is the largest, most influential dermatology group in the United States. With a membership of more than 20,000, it represents nearly all practicing dermatologists in the U.S., as well as a growing number of international dermatologists.
The weekend will feature a series of live moderated Q&A sessions:
• Adam Friedman, MD, chair of the Department of Dermatology and professor of dermatology, will speak at the Acne and Rosacea Symposium on the “Microbiome and Its Importance in Acne and Rosacea.” (April 23, 3:30 p.m.)
• Friedman will also present during the Hot Topics session on “Frenemies: Dysbiosis and Skin Disease.” (April 24, 9 a.m.)
• Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology, will speak during the Atopic Dermatitis session on “Multimorbidity of Atopic Dermatitis.” (April 24, noon)
• Silverberg will also present during the Late-Breaking Abstracts session on “The Topical Pan-JAK Inhibitor Delgocitinib in a Cream Formulation is Efficacious with a Favorable Safety Profile: Results from an 8-Week Phase 2b Dose-Ranging Trial in Atopic Dermatitis.” (April 24, 2 p.m.)
GW medical students and residents also will present posters during the meeting. Some examples include:
• Fourth-year MD student and research fellow Nagasai Adusumilli will present “Curcumin Nanoparticles as a Photoprotective Adjuvant” and “Leveraging Virtual Boot Camp to Alleviate First-Year Dermatology Resident Anxiety.”
• Second-year resident Blair Allais, MD, will present in the Gross and Micro Section on “High Grade B-cell Lymphoma Mimicking Cellulitis.”
• Kamaria Nelson, MD, dermatopharmacology fellow, and incoming first-year dermatology residents will give an oral presentation during the Gross and Micro Section on “Eosinophilic Annular Erythema Treated with Apremilast.”
More information about AAD VMX and the schedule for the meeting
